|
VENENUM Biodesign is dedicated to 1) discovering small molecule therapeutics against novel targets and partnering these discoveries with pharmaceutical/biotech companies, and 2) offering access to state-of-the-art core capabilities (assay development including protein expression and crystallography, ultra-high-throughput screening of our 5.5 million compound collection, plate production, and medicinal chemistry compound optimization) to academic institutions, research organizations and pharmaceutical companies in the US and internationally.
Our scientific staff has extensive pharmaceutical industry experience and is eager to collaborate.
Click on image for bios
|
